, for a discussion of: Operations Principal Products Distribution and Customers Competition Regulatory Matters Research and Development Strategic Imperatives for 2026 We believe we have a significant opportunity to fundamentally transform how myopia and other refractive conditions are treated. We want to be the first choice for doctors and for patients seeking visual freedom from wearing eyeglasses or contact lenses. The Company is navigating market headwinds, geopolitical factors and a dynamic ...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2026-01-02 | 0000718937-26-000004 | EDGAR | 70K words |
| 2025-02-21 | 2024-12-27 | 0000950170-25-024813 | EDGAR | — |
| 2024-02-27 | 2023-12-29 | 0000950170-24-020572 | EDGAR | — |
| 2023-02-23 | 2022-12-30 | 0001564590-23-002249 | EDGAR | — |
| 2022-02-23 | 2021-12-31 | 0001564590-22-006264 | EDGAR | — |
| 2021-02-24 | 2021-01-01 | 0001564590-21-008098 | EDGAR | — |
| 2020-02-26 | 2020-01-03 | 0001564590-20-006791 | EDGAR | — |
| 2019-02-21 | 2018-12-28 | 0001564590-19-003674 | EDGAR | — |
| 2018-02-28 | 2017-12-29 | 0001144204-18-011838 | EDGAR | — |
| 2017-03-02 | 2016-12-30 | 0001144204-17-012557 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-26 | 0001193125-25-266879 | EDGAR | 25K words |
| 2025-08-06 | 2025-06-27 | 0000950170-25-103982 | EDGAR | — |
| 2025-05-07 | 2025-03-28 | 0000950170-25-065665 | EDGAR | — |
| 2024-10-30 | 2024-09-27 | 0000950170-24-118973 | EDGAR | — |
| 2024-08-07 | 2024-06-28 | 0000950170-24-092753 | EDGAR | — |
| 2024-05-07 | 2024-03-29 | 0000950170-24-054488 | EDGAR | — |
| 2023-11-06 | 2023-09-29 | 0000950170-23-058994 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037163 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017183 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0001564590-22-036363 | EDGAR | — |
| 2022-08-10 | 2022-07-01 | 0001564590-22-028946 | EDGAR | — |
| 2022-05-04 | 2022-04-01 | 0001564590-22-017859 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-337197 | EDGAR | — |
| 2026-03-03 | 0000718937-26-000005 | EDGAR | 12K words |
| 2026-02-05 | 0001193125-26-038534 | EDGAR | — |
| 2026-02-02 | 0001193125-26-032630 | EDGAR | — |
| 2026-01-16 | 0001193125-26-014681 | EDGAR | — |
| 2026-01-15 | 0001193125-26-013622 | EDGAR | — |
| 2026-01-06 | 0001193125-26-004699 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003534 | EDGAR | — |
| 2025-12-09 | 0001193125-25-311982 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310631 | EDGAR | — |
317 total filings indexed. 285 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000718937 |
| Ticker | STAA |
| Exchange | Nasdaq |
| SIC | 3851: Ophthalmic Goods |
| Incorporated | DE |
| Website | https://www.staar.com |
| Listed | 1983-07-07 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/STAA (~200 tokens, structured JSON with cryptographic provenance)